despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..
.
"we were quite surprised to find there were no significant differences," says study author.
.
.
..
..of all car-t cell trials registered since 2001, more than half are being conducted in china. http://ndaviesco.com/Bassford-daughter-of-Sciullo-from-Changwat-Sukhothai?Vetetoson=296
.